Cormedix Inc (CRMD)
5.84
+0.47
(+8.75%)
USD |
NASDAQ |
May 03, 16:00
5.835
0.00 (0.00%)
After-Hours: 20:00
Cormedix Cash from Investing (TTM): -17.06M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -17.06M |
September 30, 2023 | -17.66M |
June 30, 2023 | -17.19M |
March 31, 2023 | -14.21M |
December 31, 2022 | -3.709M |
September 30, 2022 | -10.84M |
June 30, 2022 | -11.99M |
March 31, 2022 | -12.80M |
December 31, 2021 | -9.135M |
September 30, 2021 | -3.853M |
June 30, 2021 | 0.6615M |
March 31, 2021 | 5.915M |
December 31, 2020 | 7.426M |
September 30, 2020 | 9.570M |
June 30, 2020 | 5.850M |
March 31, 2020 | -3.070M |
December 31, 2019 | -12.02M |
September 30, 2019 | -12.32M |
June 30, 2019 | -11.85M |
March 31, 2019 | -7.975M |
December 31, 2018 | 1.555M |
September 30, 2018 | 6.622M |
June 30, 2018 | 10.70M |
March 31, 2018 | 6.766M |
December 31, 2017 | 10.36M |
Date | Value |
---|---|
September 30, 2017 | 10.01M |
June 30, 2017 | 5.641M |
March 31, 2017 | 10.03M |
December 31, 2016 | 11.42M |
September 30, 2016 | 6.714M |
June 30, 2016 | -3.212M |
March 31, 2016 | -17.05M |
December 31, 2015 | -23.61M |
September 30, 2015 | -23.62M |
June 30, 2015 | -13.40M |
March 31, 2015 | -0.0383M |
December 31, 2014 | -0.0254M |
September 30, 2014 | -0.0616M |
June 30, 2014 | -0.0553M |
March 31, 2014 | -0.0357M |
December 31, 2013 | -0.0357M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | -0.0016M |
December 31, 2011 | -0.0016M |
September 30, 2011 | -0.0016M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-17.66M
Minimum
Sep 2023
9.570M
Maximum
Sep 2020
-6.752M
Average
-10.84M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
BioXcel Therapeutics Inc | -0.02M |
Assertio Holdings Inc | 3.097M |
Verastem Inc | -44.45M |
Ocular Therapeutix Inc | -6.087M |
PAVmed Inc | 0.758M |